Skip to main content
. 2018 Sep 21;36(32):3231–3239. doi: 10.1200/JCO.2018.78.6624

Fig 3.

Fig 3.

Memory scores in patients with breast cancer and controls prechemotherapy (assessment 1 [A1]), postchemotherapy (A2), and 6 months after chemotherapy (A3; or time equivalent). Smaller values imply greater cognitive deficit. (A) Mean scores on the Delayed Match to Sample (DMS) test at the 12-second delay and corresponding 95% CIs are shown for A1, A2, and A3; (B) control-adjusted values, where the group control mean is subtracted from the patient group at each time point.